UKIPO issues formal response to Industrial Strategy IP views
22-05-2018
Regeneron forms consortium to fund exome sequencing
12-01-2018
UK government announces life sciences deal; GSK and AstraZeneca invest
11-12-2017
MSD, known as Merck and Co in the US and Canada, announced plans to launch a life sciences discovery research facility just hours ahead of the UK government’s release of its industrial strategy.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
UK government, life sciences, industrial strategy, Merck Sharpe Dohme, MSD, innovation, research
